Kotra to gain from rising spending at pharmacies


Kotra's over-the-counter (OTC) products accounted for half of its financial year 2022 revenue, says Kenanga Research.

PETALING JAYA: Kotra Industries Bhd, which is involved in the pharmaceutical value chain, is expected to continue capitalising on the rising out-of-pocket healthcare expenditure at pharmacies.

According to Kenanga Research, out-of-pocket healthcare spending in Malaysia at private pharmacies delivered a 10-year compound annual growth rate (CAGR) of 11%.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Kotra , out-of-pocket , healthcarespending , OTC , margins

Next In Business News

Singapore's December exports rise 6.1% y-o-y, weaker than expected
Bursa Malaysia buoyed by improved investor appetite
PNB offers US$300mil secured exchangeable sukuk to strengthen portfolio diversification
IMF's growth forecasts to show resilience to global trade shocks, Georgieva says
Trading ideas: Binastra, Kerjaya Prospek, D&O, Dengkil, SkyGate, NexG, Vestland, Chin Hin, SC Estate Builder, ES Sunlogy, Infomina
Wall St ends higher as banks gain on upbeat results
Oil settles down as Trump comments ease Iranian supply concerns
Property segment set for solid expansion
BLand in proposed name change
Vestland terminates three jobs worth RM551mil

Others Also Read